Janus Henderson Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Hold |
14,000
| – | – | ﹤0.01% | 1426 |
|
|
2025
Q1 | $1.66M | Hold |
14,000
| – | – | ﹤0.01% | 1374 |
|
|
2024
Q4 | $1.18M | Hold |
14,000
| – | – | ﹤0.01% | 1603 |
|
|
2024
Q3 | $1.26M | Hold |
14,000
| – | – | ﹤0.01% | 1551 |
|
|
2024
Q2 | $1.13M | Sell |
14,000
-188
| -1% | -$15.1K | ﹤0.01% | 1563 |
|
|
2024
Q1 | $1.13M | Buy |
14,188
+1
| +0% | +$80 | ﹤0.01% | 1575 |
|
|
2023
Q4 | $1.13M | Sell |
14,187
-28
| -0.2% | -$2.23K | ﹤0.01% | 1562 |
|
|
2023
Q3 | $993K | Buy |
14,215
+12
| +0.1% | +$838 | ﹤0.01% | 1559 |
|
|
2023
Q2 | $1.02M | Sell |
14,203
-21
| -0.1% | -$1.51K | ﹤0.01% | 1605 |
|
|
2023
Q1 | $877K | Buy |
14,224
+9,256
| +186% | +$571K | ﹤0.01% | 1711 |
|
|
2022
Q4 | $383K | Hold |
4,968
| – | – | ﹤0.01% | 1853 |
|
|
2022
Q3 | $222K | Buy |
+4,968
| New | +$222K | ﹤0.01% | 2357 |
|
|
2022
Q2 | – | Sell |
-4,958
| Closed | -$205K | – | 2600 |
|
|
2022
Q1 | $205K | Buy |
+4,958
| New | +$205K | ﹤0.01% | 2427 |
|
|
2021
Q2 | – | Sell |
-211,581
| Closed | -$12M | – | 1613 |
|
|
2021
Q1 | $12M | Sell |
211,581
-237,072
| -53% | -$13.4M | 0.01% | 867 |
|
|
2020
Q4 | $36.6M | Sell |
448,653
-66,230
| -13% | -$5.4M | 0.02% | 623 |
|
|
2020
Q3 | $36.7M | Sell |
514,883
-6,268
| -1% | -$447K | 0.02% | 569 |
|
|
2020
Q2 | $42.9M | Buy |
+521,151
| New | +$42.9M | 0.02% | 525 |
|